CMS Open Payments · Program Year 2024
Maryland
Maryland received $54,728,166.11 in pharmaceutical-industry payments to 14,705 physicians and 19 teaching hospitals across 304,727 transactions.
- $54.7M
- Total payments
- $47.8M
- To physicians
- $2.5M
- To teaching hospitals
- #19
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $54.7M in payments to 14,705 physicians and 19 teaching hospitals in Maryland. That ranks Maryland #19 of 59 states and territories (0.4% of the US total), averaging $3.2K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
Maryland pairs above-median payment volume with an overwhelmingly physician-directed payment mix.
- #19
- of 59 states
- 0.4%
- of the national total
- 87.3%
- to physicians vs. hospitals
- 14,705
- physicians paid
What the Data Shows for Maryland
Maryland's Open Payments file is physician-weighted: 87.3% of $54.7M went to 14,705 physicians ($3.2K each), with 4.6% on 19 teaching hospitals.
On the national dollar ranking it is still #19 of 59 (0.4% of US payments). Average transaction $179.60. Leading nature of payment: "Consulting Fee" at $12.8M (23.5% of the state file; top-three natures 66.7%).
Maryland sits in the 69th percentile (mid-pack). Just above: Washington ($59.1M). Just below: Minnesota ($50.1M). For context: top-ranked California ($342.4M) is 6.3× larger than Maryland. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in Maryland are distributed between physicians and teaching hospitals.
Physician Payments
$47.8M
87.3% of total · 14,705 recipients · $3.2K avg
Teaching Hospital Payments
$2.5M
4.6% of total · 19 hospitals · $132.3K avg
Payment Breakdown by Type
Maryland has 16 types of pharmaceutical payments. "Consulting Fee" accounts for 23.5%.
Nature concentration in Maryland
Top three Open Payments natures are 66.7% of state dollars; residual is every other reported nature
Payment categories in Maryland
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Consulting Fee | $12.8M | 4,136 | 23.5% |
| Royalty or License | $11.9M | 423 | 21.7% |
| Compensation for Services Other Than Consulting | $11.8M | 4,521 | 21.5% |
| Food and Beverage | $8.0M | 278,474 | 14.7% |
| Travel and Lodging | $3.9M | 11,854 | 7.2% |
| Grant | $2.3M | 119 | 4.2% |
| Education | $938.7K | 3,270 | 1.7% |
| Honoraria | $904.4K | 321 | 1.7% |
| Compensation for Faculty or Speaker (Medical Education) | $738.3K | 354 | 1.3% |
| Long-Term Medical Supply or Device Loan | $532.1K | 574 | 1.0% |
| Debt Forgiveness | $357.7K | 99 | 0.7% |
| Acquisitions | $266.0K | 4 | 0.5% |
| Space Rental or Facility Fees | $110.2K | 32 | 0.2% |
| Gift | $73.5K | 444 | 0.1% |
| Charitable Contribution | $10.4K | 7 | 0.0% |
| Entertainment | $7.6K | 95 | 0.0% |
Read with this Maryland Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: Washington ($59.1M)
- Next lower total: Minnesota ($50.1M)
- Nearest physician-share mix: Maine (87.2% to physicians)
- Nearest physician-share mix: Wyoming (86.7% to physicians)
- Nearest physician-share mix: Idaho (87.8% to physicians)
- National catalog for leading nature here: Consulting Fee (23.5% of Maryland)
- State payment rankings (includes Maryland at #19)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What Maryland totals can and cannot tell you
The aggregate payment figure for Maryland measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.